NOI of SEK 39m vs ABGSCe at SEK 42m Property value changes of SEK 33m – in line vs ABGSCe Net LTV of...
Redeye leaves a comment on the Q2 report published by Alzinova earlier today.
Vow published its H1 report this morning, with strong headline figures.
Redeye updates its estimates following Safeture’s Q2 report.
Redeye provides its initial take on Surgical Science’s Q2 2022 report, which came in above our estim...
Net revenue was SEK 27m, +187% Y/Y. This was above our estimates of SEK 9.
Redeye states that the Q2 report was very strong, both in terms of sales and profitability.
Redeye gives its initial take of Sileon’s second-quarter report for 2022, which came in below our ex...
Redeye is impressed by the sales progression in the past quarter.
Redeye updates its view post Embracers Q1 2022/23 and from its latest game release Saints Row, where...
Strong Q2 beat driven by Investment Management We increase our ’23e-’24e underlying EBIT by 5% 2023e...
Anima Group publicerade igår den 23 augusti 2022 Bolagets delårsrapport för det första halvåret 2022...
After the previously announced setback regarding the AGENT study, the Q2 report was largely in line ...
Redeye comments on Sprint’s Q2 2022 report, which aligned with our expectations.
Redeye comments on Spago’s Q2 2022 report, following the company strengthening its cash position and...
Rapportkommentar OssDsign rapporterade en stark försäljningsökning drivet av USA-marknaden som nu st...
EPTI publicerade den 23 augusti bolagets delårsrapport för andra kvartalet 2022.
Qlosr publicerade igår den 23 augusti 2022 bolagets delårsrapport för andra kvartalet år 2022.
Återhämtning i Q2 Arcoma redovisar intäkter för Q2 om 33,2 mkr (36 mkr) i stort i linje med vårt est...
Ett Q2 med royaltyintäkter från Dagab Omsättningen för Q2 uppgick till 3,5 mkr och 7,5 mkr för H1.
